Fight Illicit Pill Presses Act of 2024
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Fight Illicit Pill Presses Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing the issue of illegal pill presses used in the manufacture of illicit drugs. The bill was referred to the House Committees on Energy and Commerce and the Judiciary for consideration. However, the bill did not advance and is currently classified as failed or expired. There is no official summary or full text available for detailed provisions, limiting the ability to analyze specific measures or enforcement mechanisms.
This bill sought to combat the illegal use of pill presses in drug manufacturing but did not progress beyond committee referral and is now expired.
- The bill focuses on combating illicit pill presses, which are often used in the production of illegal drugs.
- It was referred to two House committees with jurisdiction over related issues: Energy and Commerce, and Judiciary.
- The bill did not advance past committee referral and is currently marked as failed or expired.
['Federal law enforcement agencies involved in drug enforcement', 'Public health and safety sectors aiming to reduce illicit drug production', 'Communities affected by illegal drug manufacturing and distribution']
['Lack of available full text limits understanding of enforcement authority and funding mechanisms', 'Potential challenges in inter-agency coordination given referral to multiple committees', 'Unclear oversight provisions due to absence of detailed legislative language']
The bill was introduced in the House during the 118th Congress and referred to relevant committees for consideration. It falls within the policy area of Crime and Law Enforcement, reflecting ongoing legislative efforts to address drug-related issues. The bill did not advance beyond committee referral and is now classified as failed or expired, indicating it did not receive a vote or further legislative action.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to increased regulatory scrutiny and enforcement actions against manufacturers and distributors of pill presses.', 'Potentially improved public safety outcomes by reducing availability of equipment used in illicit drug production.', 'Could have required additional resources for law enforcement and regulatory agencies.']
Due to the absence of the full bill text and official summary, transparency is limited regarding the specific measures, enforcement mechanisms, and funding provisions proposed. The bill's failure to advance past committee referral further restricts public and legislative oversight opportunities.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.